Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Clinical Rheumatology|December 21, 2005
A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritisSalih Pay, Nuran Türkçapar, Mukaddes Kalyoncu, et al.
Archives of Rheumatology|April 23, 2025
Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experienceElif Durak Ediboglu, Umut Kalyoncu, Dilek Solmaz, et al.
International Journal of Rheumatic Diseases|December 6, 2023
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality ratesGüllü Sandal Uzun, Arzu Taghiyeva, İbrahim Y Çakır, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure RegistryOmer Karadag, Bayram Farisogullari, Burcu Yagiz, et al.
Rheumatology (Oxford, England)|June 24, 2023
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up studyBurcu Yagiz, Nihal Lermi, Belkis N Coskun, et al.
Rheumatology International|July 6, 2021
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?Burcu Yagiz, Belkis Nihan Coskun, Yavuz Pehlivan, et al.
International Journal of Rheumatic Diseases|May 13, 2025
Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney DiseaseDilara Bulut Gökten, Mehmet Engin Tezcan, Burcu Yağız, et al.
American Journal of Ophthalmology|April 7, 2021
Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life ResultsNazife Şule Yaşar Bilge, Umut Kalyoncu, Pamir Atagündüz, et al.
Arthritis Research & Therapy|February 8, 2012
Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in TurkeyZiver Sahin, Muge Bıcakcıgil, Kenan Aksu, et al.
Clinical and Experimental Rheumatology|October 9, 2025
Behçet's disease beyond the criteria: insights from a tertiary centre in TurkeyBusra Firlatan Yazgan, Ezgi Aysu Sahin Mavi, Gozde Sevgi Kart Bayram, et al.
Pageof 14